Detalhe da pesquisa
1.
COVID-19 Protection Strategies: Lessons Learned About Epidermal Barrier Function and the Significance of Optimized Skin Care.
J Drugs Dermatol
; 23(4): 244-248, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564396
2.
Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne.
J Drugs Dermatol
; 23(6): 423-428, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834211
3.
Going Beyond Ceramides in Moisturizers: The Role of Natural Moisturizing Factors.
J Drugs Dermatol
; 23(6): 466-471, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834224
4.
Natural Moisturizing Factor-Enriched Formulations Compared to a Ceramide-Based Cream.
J Drugs Dermatol
; 23(3): 141-145, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443132
5.
Topical Clindamycin in the Management of Acne Vulgaris: Current Perspectives and Recent Therapeutic Advances.
J Drugs Dermatol
; 23(6): 438-445, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834223
6.
New Insights Into Systemic Drivers of Inflammation and Their Contributions to the Pathophysiology of Acne.
J Drugs Dermatol
; 23(2): 90-96, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306144
7.
Consensus Statements on the Use of Novel Formulations of Isotretinoin: A Modified Delphi Process.
J Drugs Dermatol
; 23(6): 429-432, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834212
8.
Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.
J Drugs Dermatol
; 23(2): 54-60, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306124
9.
INDIVIDUAL ARTICLE: Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES Study.
J Drugs Dermatol
; 23(2): SF405634s5-SF405634s11, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306151
10.
INDIVIDUAL ARTICLE: Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES Study.
J Drugs Dermatol
; 23(2): SF405634s12-SF405634s18, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306152
11.
Efficacy and safety of microencapsulated benzoyl peroxide and microencapsulated tretinoin for the treatment of acne vulgaris: Results from two phase 3 double-blind, randomized, vehicle-controlled studies.
J Am Acad Dermatol
; 89(4): 719-727, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356627
12.
Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial.
J Am Acad Dermatol
; 89(5): 936-944, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37172733
13.
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
J Am Acad Dermatol
; 89(5): 927-935, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656094
14.
Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion.
J Drugs Dermatol
; 22(2): 132-138, 2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745378
15.
Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.
J Drugs Dermatol
; 22(12): 7691, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051842
16.
Long-term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified-release capsules once daily.
Dermatol Ther
; 35(1): e15180, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713539
17.
Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacy.
Dermatol Ther
; 35(3): e15275, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923732
18.
Never Give Up! Continued Progress in Development of Topical Therapies for Acne Is a Good Thing.
J Drugs Dermatol
; 21(6): 571-572, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674766
19.
Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Adult Age Groups.
J Drugs Dermatol
; 21(6): 587-595, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674760
20.
Efficacy and Safety of Tazarotene 0.045% Lotion in Caucasian Adults With Moderate-to-Severe Acne.
J Drugs Dermatol
; 21(10): 1061-1069, 2022 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219057